Lenvatinib and Pembrolizumab for Advanced Endometrial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update
J. Clin. Oncol 2023 Jan 06;[EPub Ahead of Print], V Makker, C Aghajanian, AL Cohn, M Romeo, R Bratos, MS Brose, M Messing, L Dutta, CE Dutcus, J Huang, EV Schmidt, R Orlowski, MH TaylorFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.